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(1,3)-β-D-GlucanA membrane-embedded curdlan synthase (CrdS) from Agrobacterium is believed to catalyse a repetitive ad-
dition of glucosyl residues from UDP-glucose to produce the (1,3)-β-D-glucan (curdlan) polymer. We report
wheat germ cell-free protein synthesis (WG-CFPS) of full-length CrdS containing a 6xHis afﬁnity tag and ei-
ther Factor Xa or Tobacco Etch Virus proteolytic sites, using a variety of hydrophobic membrane-mimicking
environments. Full-length CrdS was synthesised with no variations in primary structure, following analysis of
tryptic fragments by MALDI-TOF/TOF Mass Spectrometry. Preparative scale WG-CFPS in dialysis mode with
Brij-58 yielded CrdS in mg/ml quantities. Analysis of structural and functional properties of CrdS during pro-
tein synthesis showed that CrdS was co-translationally inserted in DMPC liposomes during WG-CFPS, and
these liposomes could be puriﬁed in a single step by density gradient ﬂoatation. Incorporated CrdS exhibited
a random orientation topology. Following afﬁnity puriﬁcation of CrdS, the protein was reconstituted in
nanodiscs with Escherichia coli lipids or POPC and a membrane scaffold protein MSP1E3D1. CrdS nanodiscs
were characterised by small-angle X-ray scattering using synchrotron radiation and the data obtained
were consistent with insertion of CrdS into bilayers. We found CrdS synthesised in the presence of the
Ac-AAAAAAD surfactant peptide or co-translationally inserted in liposomes made from E. coli lipids to be cat-
alytically competent. Conversely, CrdS synthesised with only Brij-58 was inactive. Our ﬁndings pave the way
for future structural studies of this industrially important catalytic membrane protein.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
The bacterial (1,3)-β-D-glucan, also known as curdlan, is an extra-
cellular polysaccharide that is important for cell structure and physi-
ology of prokaryotic Agrobacterium sp. [1]. Curdlan has extensive
practical and commercial applications in food, cosmetic, pharmaceu-
tical and building industries as previously outlined [1–3]. However,rij-58, polyoxyethylene-(20)-cetyl-
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nisms that underlie its biosynthesis have not been described at the
molecular levels [2,3].
Themolecular genetics of curdlan production byAgrobacterium sp. has
been extensively studied [1–3]. Curdlan synthases (CrdS) [UDP-glucose:
(1,3)-β-D-glucan 3-β-D-glucosyltransferase; EC 2.4.1.34] are conﬁned
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Table 1
Primers used for ligation-based cloning of the pEU-His-CrdS, pEU-His-Xa-CrdS and
pEU-His-TEV-CrdS DNA fusions.
Construct Primer Sequencea
pEU-His-CrdS 5′ Forward
5′ Reverse
CTCGAGAGTGCTGAAGGTGAC
GCGGCCGCTTATCCTCAGAATGCCCGTGCGAG
pEU-His-Xa-CrdS 5′ Forward
5′ Reverse
CTCGAGATTGAAGGACGAAGTGCTGAACGTGAC
GCGGCCGCTTATCCTCAGAATGCCCGTGCGAG
pEU-His-TEV-CrdS 5′ Forward
5′ Reverse
CTCGAGAGTGCTGAAGGTGAC
GCGGCCGCTTATCCTCAGAATGCCCGTGCGAG
a Bold types indicate the XhoI (forward) and NotI (reverse) restriction sites. The
italicised and underlined sequences indicate the proteolytic Factor Xa site and the
stop-Gly-stop motif, respectively. The remainder of the sequences corresponds to cod-
ing regions of CrdS.
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has been classiﬁed by CAZy in the GT2 family of glycosyl transferases
[3,4]. The cDNA of CrdS from Agrobacterium sp. [1] translates into a pro-
tein of 654 amino acid residues. Bioinformatics evaluations predict that
CrdS has a Nout–Cin topology, harbours seven membrane spanning
α-helices and contains a single large cytoplasmic region inserted between
the 3rd and 4thmembraneα-helices [2], representing a putative catalytic
module (CM). CM contains characteristic catalytic and substrate binding
signatures Asp, Asp, Asp (D, D, D) and GlnxxArgTrp (QxxRW) found in
other glucosyltransferases classiﬁed in the GT2 family [1–4]. CrdS is pre-
dicted to contain at least one pair of bonded cysteines located in CM, al-
though the existence of this disulphide bridge is not supported by
experimental evidence [2]. The 3D structures of the GT2 enzymes eluci-
dated by X-ray crystallography comprise a soluble bacterial spore-coat
protein [5], a chondroitin polymerase enzyme from Escherichia coli [6] in-
volved in synthesis of chondroitin sulfate, a putative glycosyltransferase
from Bacteroides fragilis [Protein Data Bank (PDB) accession 3BCV, Polani,
Kumaran, Burley and Swaminathan, unpublished data] and a recently de-
termined teichoic acid polymerase from Staphylococcus epidermidis [7].
Previously, cDNA encoding CM of CrdS cloned into the pET-32a(+)
vector containing thioredoxin, and into the Champion™ pET SUMO sys-
tem containing a SUMO (small ubiquitin-related modiﬁer) coding re-
gion enabled high yield expression of CM, in the form of inclusion
bodies [2]. The former vector was chosen because it is recognised to fa-
cilitate disulﬁde bond formation in the reducing environment of E. coli
[8], alleviates toxic effects of recombinant protein production on host
cells, prevents target proteins fromproteolytic degradation and acceler-
ates expression of proteins in a soluble form [9]. The inclusion bodies
produced in E. coli were refolded using a range of buffers and
non-surfactant sulfobetaines [2]. Refolded, chimeric CM was found to
be inactive, although it showed a native-like circular dichroism spec-
trum [2].
The objective of the present work was to produce full-length CrdS
through a eukaryotic wheat germ cell-free (CF) protein synthesis
(WG-CFPS) expression system that enables rapid production of pro-
teins [10]. CFPS systems based on cellular extracts, have emerged re-
cently as efﬁcient and versatile tools for the production of complex
integral membrane proteins. Here, the entire process of protein pro-
duction encompassing transcription and translation steps takes
place in vitro [12–15]. The CFPS systems overcome many of the tech-
nical hurdles of in vivo membrane protein production as cell viability
and protein production are essentially decoupled [14,16]. The CF sys-
tems, not being enclosed by a membrane are open and accessible, and
allow supplementation of target-speciﬁc additives such as stabilisers,
substrates, ligands, chaperones, surfactants and other components at
any time during a CF reaction [16,17]. Moreover, the option to
co-translationally insert membrane proteins directly into artiﬁcial hy-
drophobic environments often eliminates a need for reconstitution of
membrane proteins into lipid environments [18]. In the past twenty
years, a variety of extracts, conﬁgurations and expression modes
have been established, developed and perfected [19]. WG-CFPS has
been used for synthesis of mainly radio-labelled polypeptides in the
past and only in recent years has substantial progress in protein
yields of membrane and multi-domain proteins been achieved
[10,11]. This progress has been primarily due to the removal of compo-
nents causing damage to ribosomes and mRNA, so CFPS can be
sustained for several days provided reaction substrates are replenished
[19,20]. Last but not least, robotic automation of WG-CFPS has been
achievedwith the advent of robotised synthesisers and associated tech-
nical progression [21,22].
Our work with recombinant CrdS is aimed at a long-term goal to
determine the three-dimensional (3D) structure of this integral
membrane protein. In the previous work, the full-length form of
CrdS was not produced in the E. coli host and only truncated forms
were obtained [2]. This led us to explore new approaches towards
stable expression of full-length CrdS. We became interested indeployment of particular avenues, such as co-translational insertion
of CrdS in liposomes and application of nanodiscs. The emergence of
nanodiscs as a tool to study structural aspects of membrane proteins
in a near-native environment has gained considerable interest in the
past decade [23,24]. During the process of spontaneous nanodisc
self-assembly, the surfactant-solubilised membrane protein becomes
surrounded by an annular lipid-bilayer patch, which is held together
by a recombinant membrane scaffold protein (MSP). Following puri-
ﬁcation by size-exclusion chromatography (SEC), a uniform popula-
tion of soluble, stable and correctly assembled membrane protein
occupied nanodiscs is usually obtained [23,24].
In the current work, full-length CrdS was sub-cloned into the
pEU-EO1™ plasmids for WG-CFPS, containing a 6xHis afﬁnity tag and
either Tobacco Etch Virus (TEV) or Factor Xa proteolytic sites.We inves-
tigated bilayer and dialysis modes of WG-CFPS and assessed yields of
CrdS in the presence of a range of surfactants and surfactant peptides.
Following co-translational insertion of CrdS in artiﬁcial liposomes, we
demonstrated single-step puriﬁcation by ﬂoatation through density
gradient ultra-centrifugation. Furthermore, with the goal of structural
studies, we assembled and puriﬁed CrdS nanodiscs to near homogene-
ity in two distinct lipid environments and characterised them by
small-angle X-ray scattering (SAXS) using synchrotron radiation [25].
Synthesised CrdS was analysed by Matrix-Assisted Laser Desorption
Ionization-Time of Flight Mass Spectrometry (MALDI-TOF/TOF MS)
and assayed for catalytic activity.
2. Materials and methods
2.1. Chemicals and reagents
The sources of oligonucleotide primers, restriction and DNA-
modifying enzymes, plasmid extraction kits, EDTA-free Complete Pro-
tease Inhibitor Cocktail tablets and other chemicals were described
previously [2]. All lipids, except asolectin (Sigma, St. Louis, MO,
USA) were purchased from Avanti Polar Lipids (Alabaster, AL, USA).
2.2. Recombinant plasmid construction
The full-length coding region of CrdSwas ampliﬁed by PCR using the
5′ primer pairs (Table 1) from the pVS1512 plasmid of an 8.8 kb EcoRI
Agrobacterium genomic fragment containing the crdASC genes [2]. The
ampliﬁed fragments were cloned into the pGEM-T Easy vector system
(Promega, Madison, WI, USA). For DNA ampliﬁcations the E. coli strain
DH5α (Invitrogen, Carlsbad, CA, USA) was transformed with pGEM-
His-CrdS, pGEM-His-TEV-CrdS and pGEM-His-Xa-CrdS constructs as
recommended by the manufacturer. The plasmids were isolated and
digested with XhoI and NotI, and the CrdS DNA fragments were
sub-cloned in-frame into the pEU-EO1-HIS-TEV-MCS™ vector (CellFree
Sciences, Tsurumi-ku, Yokohama, Japan) to generate the pEU-His-CrdS
and pEU-His-TEV-CrdS constructs, and into the pEU-EO1-MCS™ vector
(CellFree Sciences) to yield the pEU-His-Xa-CrdS construct. The three
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and the plasmid DNA was sequenced in both directions.
2.3. Wheat germ cell-free protein synthesis of CrdS
Wheat germ cell-free protein synthesis (WG-CFPS) of CrdS was
performed sequentially through theuncoupled transcription and transla-
tion reactions. Care was taken to prevent RNAse contamination through-
out by using RNase-free water (MP Biomedicals, Fountain Parkway
Solon, Ohio, USA) and RNase AWAY® (Molecular BioProducts, San
Diego, CA, USA) to sanitise the workspace.
2.3.1. Preparation of plasmid DNA
DNA was isolated from the E. coli cells transformed with the
pEU-His-CrdS, pEU-His-TEV-CrdS and pEU-His-Xa-CrdS constructs using
the PureYield™ PlasmidMiniprep System (Promega). The quality of puri-
ﬁed DNA, expressed as A260/A280 was within a range of 1.8–2.0. The DNA
was used at a concentration of 1 μg/μl.
2.3.2. Transcription (preparation of mRNA)
Plasmid DNA of the pEU-His-CrdS, pEU-His-TEV-CrdS and pEU-
His-Xa-CrdS constructs (2.5 μg) was combined with a transcription
buffer (CellFree Sciences) and the nucleotide-tri-phosphate (NTP)
mix (ATP, CTP, GTP, and UTP each at 3 mM) (Roche, Indianapolis,
USA), SP6 RNA polymerase (1 U/μl) (Promega), RNAsin (1 U/μl)
(Promega) and RNase free water (MP Biomedicals) were added to a
total volume of 25 μl [20]. Synthesis of mRNA proceeded at 42 °C for
2.5 h. The quality of synthesisedmRNAwas conﬁrmed by 1% (w/v) aga-
rose gel electrophoresis.
2.3.3. Translation (synthesis of CrdS)
Translationwas performed through either bilayermode in the 150 μl
total reaction volume or through dialysis mode of 50 μl internal reaction
volumes, in a Slide-A-Lyser Mini dialysis cup, molecular mass cut-off
10 kDa (Thermo Scientiﬁc, Rockford, IL, USA). The translation reactions
were setup in the dialysis buffer (CellFree Sciences) containing 0.3 mM
L-amino acids (CellFree Sciences) with 10 μl mRNA/25 μl reaction mix.
Translation reactions contained the WEPRO wheat germ extract
(6.3 μl/25 μl) (CellFree Sciences), creatine-phosphokinase (0.4 μg/μl)
(Roche) and RNase free water (MP Biomedicals). Biotinylated tRNA
(1.5 μl/25 μl) (Promega) was added during translation in speciﬁc cases
to allow for detection of CrdS through a streptavidin-coupled assay.
The synthesis in bilayer mode was carried out as described [26] at
20 °C for 20 h, and the synthesis in dialysis mode proceeded according
to [20] at 20 °C for up to 72 h, with the supply of a fresh dialysis buffer
after 24-hour time intervals. The translation mixture in dialysis mode
was placed in dialysis cups and suspended in a buffer reservoir
containing 0.6 ml of the dialysis buffer (CellFree Sciences). The transla-
tion reaction mixture was supplemented with surfactants, surfactant
peptides, amphipols and liposomes, prepared as speciﬁed below.
2.3.4. CrdS synthesis with surfactants
Non-ionic and zwitterionic surfactants of alkyl-glycosides, ste-
roids, polyoxyethylene-alkyl-ethers, polyethyleneglycol and long-chain
phosphoglycerol derivatives were tested above their critical micellar
concentrations (CMC) in translation reactions. The list of surfactants,
their concentrations and sources are summarised in Table 2.
2.3.5. CrdS synthesis with surfactant peptides
The CrdS synthesis proceededwith 1, 2 and 4 mM concentrations of
the acetylated Ac-AAAAAAD (Ac-Ala-Ala-Ala-Ala-Ala-Ala-Asp), Ac-IIID
(Ac-Ile-Ile-Ile-Asp) and Ac-LLLK-NH2 (Ac-Leu-Leu-Leu-Lys-NH2) sur-
factant peptides. The peptides were synthesised by Mimotopes
(Clayton, Victoria, Australia) and dissolved in RNase free water (MP
Biomedicals) to prepare 50 mM stock concentrations.2.3.6. CrdS synthesis with amphipols
CrdS synthesis proceeded with amphipol A8-35 (Anatrace, Santa
Clara, CA, USA) and styrene maleic acid (SMA) at concentrations
ranging from 0.5% to 4%. SMA was kindly provided by Dr Timothy
Knowles (University of Birmingham, UK).
2.3.7. CrdS synthesis with liposomes
The synthesis of CrdS proceeded with liposomes prepared at ﬁnal
lipid concentrations of 2.5 mg/ml, 5 mg/ml and 10 mg/ml either by
using a single lipid component or a mixture of lipids; in the latter
case DOPG was mixed with POPE in a 2:3 ratio, by weight. The list
of lipids used, their formulae and sources are given in Table 3. CrdS
quantiﬁcation was performed using the ImageJ software [27] from
scanned Western blot images. A CrdS calibration curve was based
on known amounts of BSA. The liposomes were prepared as follows.
The pre-weighted lipid powder in a glass-tube was dissolved in chlo-
roform and dried on a rotary evaporator followed by purging with a
stream of nitrogen to remove chloroform. The resultant lipid coating
in the glass test-tube was dried for 2 h under vacuo to remove
every trace of chloroform. The dried lipid ﬁlm was dissolved in the
lipid re-hydration buffer (25 mM HEPES, 100 mM NaCl, pH 7.5) to a
ﬁnal concentration of 100 mg/ml. The tube was constantly agitated
until dissolved and was kept above the transition temperature of a
particular lipid, which varied between−20 °C and 23 °C. The suspen-
sion was extruded 21 times, above the lipid transition temperature,
using the Avestin LiposoFast extruder (Avestin, Ontario, Canada)
through polycarbonate ﬁlters with pore sizes of 100 or 400 nm to
produce a population of unilamellar liposomes.
2.4. Puriﬁcation of CrdS proteo-liposomes through ﬂoatation on Accudenz
gradient
A 75 μl aliquot taken from a WG-CFPS translation reaction
containing liposomes was mixed with 75 μl of 80% (w/v) Accudenz
(Accurate Chemical and Scientiﬁc, Westbury, NY) prepared in
25 mM HEPES, pH 7.5, containing 100 mM NaCl and 10% (v/v) glyc-
erol. Accudenz is a non-ionic, biologically inert density gradient
component. The mixture was transferred to an ultra-clear centrifuge
tube (Beckman Coulter, Fullerton, CA, USA), successively overlaid
with 350 μl of 30% (w/v) Accudenz in the same buffer and with 100 μl
of 25 mM HEPES, pH 7.5, containing 100 mM NaCl. The mixture was
centrifuged at 100,000×g for 4 h at 4 °C in the L-80 XP ultra-centrifuge
using a SW55Ti rotor (Beckman Coulter). After ultra-centrifugation,
60 μl fractions were sequentially collected from the top of the gradient
and examined by SDS-PAGE (sodium dodecyl sulphate-polyacrylamide
gel electrophoresis) and Western immuno-blot analyses as described
below.
2.5. Puriﬁcation of CrdS through ImmobilizedMetal Afﬁnity Chromatography
(IMAC)
The CrdS protein synthesised in the presence of Brij-58 in dialysis
mode was equilibrated in 10 mM Na2HPO4·2 H2O, 150 mM NaCl and
10 mM imidazole, pH 8.0, and added to the Ni-NTA resin (Bio-Rad,
Hercules, CA, USA) pre-equilibrated in the same buffer. The mixture
was incubated for 16 h at 4 °C and loaded onto a 1×10 cm
Econo-column (Bio-Rad). The ﬂow-through was collected and the
resin was washed four times with ﬁve bed volumes of a wash buffer
(20 mM Na2HPO4·2 H2O, 300 mM NaCl, 20 mM imidazole, pH 8.0)
containing 0.04% (w/v) Brij-58. The CrdS protein was eluted six times
with one bed volume of the buffer speciﬁed above that contained
50 mM, 100 mM, 150 mM, 200 mM, 250 mM and 500 mM imidazole.
The fractions were evaluated by SDS-PAGE and Western immuno-blot
analyses using either a mouse IgG2a isotype anti-6xHis monoclonal an-
tibody from Clontech (Takara Bio, Shiga, Japan) or rabbit polyclonal an-
tibody, raised against the intracellular catalytic region of CrdS [2]. The
Table 2
Surfactants used during wheat germ cell-free synthesis of CrdS.
Surfactants Short name Final concentration x CMC Sourcea
n-Dodecyl-β-D-maltoside DDM 0.8% (w/v) 12 Anatrace
n-Decyl-β-D-maltoside DM 0.08% (w/v) 9.2 Anatrace
n-Octyl-β-D-glucopyranoside β-OG 0.5% (w/v) 1.3 Anatrace
Digitonin 0.4% (w/v) 4.5 Sigma
Polyoxyethylene-(20)-cetyl-ether (C16⁄20) Brij-58 0.04% (w/v) 4.7 Sigma
Polyoxyethylene-sorbitan-monolaurate 80 Tween 80 3% (v/v) 1.5 Sigma
Polyethylene-glycol-p-1,1,3,3-tetramethyl-butylphenyl-ether Triton X-100 0.5% (v/v) 33.5 BDH
Nonylphenyl-polyethylene-glycol NP40 0.5% (w/v) 1.3 Merck
3-[(3-Cholamidopropyl)dimethylammonio]-1-propansulfonate CHAPS 0.5% (w/v) 1.8 Anatrace
a The sources are Anatrace (Santa Clara, CA, USA), Sigma (St. Louis, MO, USA), BDH Chemicals (Poole, Dorset, UK) and Merck Chemicals (Darmstadt, Germany).
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tive contributions of CrdS and other protein components that were
detected on the SDS-PAGE gels.
2.6. Preparation of CrdS nanodiscs
Nanodiscs were prepared [23,24] with modiﬁcations as described
below. The CrdS protein was puriﬁed by IMAC as described above,
and concentrated in a Microcon Ultracel YM10 microconcentrator,
molecular mass cut-off 10 kDa (Millipore, Billerica, USA). Approxi-
mate protein concentration of CrdS was calculated using a Qubit Pro-
tein Assay Kit (Invitrogen) and SDS-PAGE. The lipid components of
nanodiscs comprised either the E. coli total lipid extract or POPC
(Avanti Polar Lipids, Alabaster, AL, USA) that were prepared essential-
ly as described for liposomes, except that sodium cholate (Sigma) was
added to the lipid re-hydration buffer such that the ﬁnal concentra-
tion during reconstitution was between 20 and 40 mM. The plasmid
encoding MSP1E3D1, acquired from Addgene (Cambridge, MA, USA)
was prepared as described [28,29]. Empty POPC nanodiscs were pre-
pared at a reconstitution ratio of 130:1 (lipid:MSP), while the nanodiscs
containing CrdS were prepared at the 0.5:120:1 (CrdS:lipid:MSP) ratioTable 3
Lipids used for preparation of liposomes for wheat germ cell-free synthesis of CrdS.
Lipid Short
name
1,2-Dimyristoyl-sn-glycero-3-phosphocholine DMPC
1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine POPC
1,2-Dioleoyl-sn-glycero-3-phosphocholine DOPC
1,2-Dioleoyl-sn-glycero-3-phospho-(1′-rac-glycerol) DOPG
1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine POPE
1,2-Dioleoyl-3-trimethylammonium-propane DOTAP
Asolectin Asolectin
E. coli total lipid extract –
a Z, A and C indicate zwitterionic, anionic and cationic lipids, respectively.in a total volume of 225 μl. The solubilised components were mixed
and incubated under rotation for 2 h at 4 °C. Biobeads SM-2 (Bio-Rad)
were added to the mixture at 0.5 g/ml to facilitate surfactant removal
and to initiate nanodisc assembly. After 16 h, a hole was pierced at
the bottom of the test tube using a 0.4 mm needle and the nanodiscs
were collected by centrifugation (1500×g, 2 min, 22 °C) into a new
test tube. Nanodisc samples were re-centrifuged (10,000×g, 2 min,
22 °C) to remove precipitates before SEC. The presence of CrdS protein
in nanodiscs was examined by SDS-PAGE and Western immuno-blot
analyses on a polyvinylidene diﬂuoride (PVDF) membrane with detec-
tion using a mouse 6xHis monoclonal antibody (Clontech).
2.6.1. Puriﬁcation of the CrdS nanodiscs through SEC
TheCrdS nanodiscswere puriﬁed at room temperature on a Superdex
200 10/300 GL column (GE Healthcare, Piscataway, NJ, USA) connected
to an ÄKTA™ Puriﬁer UPC-10 system (GE Healthcare). The void volume
of the Superdex column was determined with Blue Dextran. After
pre-equilibration of the column in TBS buffer (40 mM Tris, 0.3 M NaCl,
pH 7.4), samples (225 μl) were pre-ﬁltered through 0.45 μm nylon
ISO-Disc ﬁlters (Supelco, Bellefonte, PA, USA) and run at a ﬂow rate of
0.5 ml/min in TBS on the ÄKTA™ Puriﬁer. Peaks were monitored atChargea Structure
Z
Z
Z
A
Z
C
Z Not applicable
– Not applicable
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concentrated in a Microcon Ultracel YM10 micro-concentrator to ap-
proximately 200 μl volumes and kept at 4 °C until analysis.2.7. Analysis of CrdS nanodiscs by small-angle X-ray scattering using
synchrotron radiation
Small-angle X-ray scattering (SAXS) data of CrdS nanodiscs were
collected on the SAXS/WAXS beamline of the Australian Synchrotron
(Melbourne, Australia) using a Pilatus-1M pixel-array detector
(Dectris, Switzerland). For each data set 25 frames of a 2-second ex-
posure time were collected from a sample moving through the X-ray
beam at a constant 5 μl/s ﬂow rate in a temperature-controlled
1.5 mm quartz capillary. Solutions of CrdS inserted in the E. coli
total lipid extract or POPC nanodiscs were measured at 30 °C in TBS
buffer at a single MSP-based protein concentration (~0.1 mg/ml).
The sample-to-detector distance was 1.6 m, covering a range of mo-
mentum transfer 0.01 Å-1bqb0.6 Å-1 (q=4πsinθ/λ, where 2θ is the
scattering angle and λ=1.03 Å is the X-ray wavelength). Comparison
of successive 2-second frames revealed no detectable radiation damage.
Data from the detector were normalised to the transmitted beam inten-
sity, averaged and scattering of the buffer solutions was subtracted
using the ScatterBrain software package available at the Australian
Synchrotron. The SAXS proﬁles were analysed using the latest cross-
platform ATSAS package [30] and scattering density distributions
were determined by indirect Fourier transformation (IFT) using the
program GNOM [31].2.8. SDS-PAGE, Western immuno-blot analyses and protein determination
Typically, 5 μl of CF reactions was evaluated by SDS-PAGE analysis
as described [2], except that prior to loading on SDS-PAGE gels, the
protein samples were incubated for 30 min at 37 °C in the SDS-
PAGE loading buffer. The proteins contained in CF reactions included
newly synthesised CrdS and wheat germ extract components. The
overall protein concentration varied between 5 and 6 mg/ml. The
Western immuno-blot analysis [2] was carried out with 0.45 μm PVDF
transfer membranes (Amersham Biosciences, Little Chalfont, Bucking-
hamshire, UK). Working dilutions of antibodies were as follows:
anti-His 1:4000 (v/v), anti-CrdS 1:4000 (v/v) and secondary antibody
1:5000 (v/v). Working solutions of antibodies were prepared in
25 mM Tris–HCl buffer, pH 7.5 containing 137 mM NaCl, 3 mM KCl
and 0.05% (w/v) Tween 20. Blots were incubated with antibodies for a
duration between 1 to 16 h with gentle agitation at 4–8 °C. The blots
were developed with the Novex® ECL HRP Chemiluminescent Sub-
strate Reagent Kit (Invitrogen) or with the BCIP/NBT-purple liquid re-
agent (Sigma) according to the manufacturer's instructions and the
images were scanned (Clinx Science Instruments, Shanghai, China).
Where Transcend tRNA was used, immuno-blot detection was carried
out via streptavidin conjugated with the alkaline phosphatase chromo-
gen (Sigma) and the membranes were developed with the BCIP/
NBT-purple liquid reagent until a desired intensity was achieved. Pro-
tein staining on SDS-PAGE gels proceeded either by Coomassie Brilliant
Blue R-250 (Sigma) [2] or through SilverQuest Silver Staining Kit
(Invitrogen). Total protein staining on PVDF membranes proceeded
with Ponceau S (Sigma). Protein concentration was determined using
the Qubit Protein Assay Kit (Invitrogen) or by the Protein Assay Kit,
based on a Coomassie Brilliant Blue G-250 dye shift (Bio-Rad) [2]. Preci-
sion Plus protein molecular mass standards were from Bio-Rad. Purity
of CrdS preparations resolved by IMAC and density gradient centri-
fugation was determined visually based on relative contributions
of individual protein bands on SDS-PAGE gels. Semi-quantitative es-
timation of protein content on SAS-PAGE gels was based on known
amounts of BSA.2.9. Other procedures
2.9.1. Tryptic mapping of CrdS by Matrix-Assisted Laser Desorption
Ionization-Time of Flight Mass Spectrometry
The band corresponding to synthesised CrdS with Brij-58 in dialy-
sis mode, was excised from the SDS-PAGE gel and placed in sterile
Milli-Q water. The protein was digested with trypsin and the peptide
mixture was analysed via MALDI-TOF/TOF MS. The MS and corre-
sponding MS/MS spectra were combined and submitted to a Mascot
database search as described [2].
2.9.2. CrdS proteo-liposomal particle sizing
CrdS proteo-liposomes (60 μl fraction 3 following the Accudenz
density ultra-centrifugation) and empty liposomes were centrifuged
(10,000×g, 2 min, 22 °C), the pellet was re-suspended in 50 mM
MOPS-KOH buffer, pH 7.8 to a volume of 150 μl and dialysed in the
D-Tube™ Dialyzer Mini tubes (Novagen, Madison, WI, USA) for 16 h
at 4 °C against the same buffer to remove Accudenz. The dialysed,
non-concentrated proteo-liposomes (50 μl) were mixed with 950 μl
of the 50 mMMOPS-KOH buffer, pH 7.8. The diameter of the liposomes
was determined using dynamic light scattering with the NICOMP 380
Particle Sizing Systems (Santa Barbara, CA, USA) operating in vesicle
mode and the data was weighted on a number of liposomes.
2.9.3. Liposome-associated topology of CrdS
CrdS (60 μg) in the DMPC liposomes was digested in 50 mM Tris–
HCl, pH 8.0, 0.5 mM EDTA and 1 mM DTT with the TEV protease
(2 μg) at room temperature for 24 h. The TEV protease was prepared
in-house using the pRK793 expression plasmid [32]. Topology of CrdS
was analysed throughWestern immuno-blot analysis with anti-6xHis
antibody (Clontech) as described above.
2.9.4. Transmission electron microscopy (TEM) of liposomes and CrdS
nanodiscs
CrdS-occupied and empty DMPC liposomes were puriﬁed through
ﬂoatation in an Accudenz density gradient as described above. About
20 μl of the puriﬁed, non-concentrated specimen of liposomes from
fraction 3 was placed on a thin piece of paraﬁlm. The carbon coated
grid was ﬂoated on the droplet for 10 min to let liposomes absorb.
The grids were washed thrice with 50 mM HEPES, pH 7.5 containing
100 mM NaCl, followed by sterile Milli-Q water and air dried. The
grids were stained with aqueous 0.5% (w/v) uranyl acetate (Sigma)
and washed ﬁve times with water and air dried. For nanodiscs, both
empty and CrdS-assembled discs were imaged prior to puriﬁcation
through SEC. Crude nanodiscs were absorbed for 1 min onto collodi-
on and carbon coated nickel grids that were washed as described
above, stained with aqueous 2% (w/v) uranyl acetate and processed
as speciﬁed for liposomes. The liposomes and nanodiscs were imaged
on the transmission electronmicroscope Philips CM 100 (FEI, Hillsboro,
Oregon, USA) operated at 80 kV, at the Adelaide Microscopy Centre of
the University of Adelaide.
2.9.5. (1,3)-β-D-Glucan synthase activity
The reaction mixtures contained 3.4 mM UDP-[3H]-glucose (speciﬁc
activity 10–45 Ci/mmol) (Perkin Elmer, Waltham, MA, USA), 80 μg
α-amylase, 0.27 mM GTP, 9 mM MgCl2 (all from Sigma), 2.2 mM
laminaribiose (Megazyme, Bray, Wicklow, Ireland) and 10 μl of enzyme
samples [33,34]. The enzyme samples were taken from CF reactions and
represented either non-concentrated CrdS synthesised with Brij-58 or
Ac-AAAAAAD, and CrdS co-translationally inserted in the E. coli total
lipid extract liposomes. The enzyme activities of CrdS reconstituted in
the E. coli total lipid extract or POPC nanodiscs were also measured.
The mixed membrane fraction isolated from Saccharomyces cerevisiae,
as described below, was used as a positive control for activity measure-
ments [33,34]. The (1,3)-β-D-glucan synthase reactions incubated at
25 °C for various time intervals were stopped by adding 50 μl of
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Fig. 1. SDS-PAGE of WG-CFPS translation reactions performed in bilayer mode and
supplemented with DMPC liposomes (10 mg/ml) and mRNA of His-CrdS, His-Xa-CrdS
and His-TEV-CrdS in lanes 1–3, respectively. Lane 4 contains the reaction lacking mRNA.
The black arrows point to the synthesised CrdS proteins that migrate to a region of
56–60 kDa; theoretical masses of the CrdS proteins are between 73 and 76 kDa. St. indi-
cates molecular mass standards.
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Millipore ﬁlter method [34]. The radioactivity incorporated into (1,3)-
β-D-glucan, which represents the product of the synthetic reaction, was
measured by scintillation counting using the EcoLite Scintillation ﬂuid
(MP Biomedicals) and a LS6500 Scintillation Counter (Beckman Coulter).
The mixed membrane fraction of S. cerevisiae was prepared from
cells grown in the YPD (yeast extract-peptone-dextrose) medium at
28 °C. The cells were harvested in the early logarithmic phase of growth.
Cell pellets were resuspended in buffer A [25 mMHEPES, pH 7.8, 5 mM
EDTA, 10 mM NaF, 1 mM phenylmethylsulphonyl ﬂuoride, 1 mM DTT,
EDTA-free Complete Protease Inhibitors and 30% (v/v) glycerol] and
disrupted with glass beads (Sigma) in a Bead-Beater (BioSpec Products,
Bartlesville, OK, USA). The disintegrated cells were centrifuged
(12,000×g, 10 min, 4 °C), the pellet was re-suspended in buffer A,
transferred to the Polyallomer centrifuge tubes (Beckman Instruments,
Fullerton, CA, USA) and centrifuged (100,000×g, 50 min, 4 °C). The
resulting pellet was resuspended in buffer A with 2 μM GTP and 5 mM
UDP-glucose, and stored at −80 °C in aliquots. The (1,3)-β-D-glucan
productwas characterised asdescribed [34]. Here, the radioactive product
was hydrolysed by (1,3)-β-D-exo-glucanase from Mollusc (Sigma) for
16 h at 30 °C and the remaining radioactivity was measured by scintilla-
tion counting as described above. Treatments of radioactive products by
boiled (1,3)-β-D-exo-glucanase and α-amylase (Sigma) were conducted
for 16 h at 30 °C and remaining radioactivity was estimated.
3. Results
3.1. Construction of pEU-EO1™ expression plasmids for wheat germ
cell-free protein synthesis
PCR-ampliﬁed full-length cDNA of CrdS was cloned into the pGEM-T
Easy vector system, using the primers listed in Table 1. The ampliﬁed
CrdS coding regions inserted in the pGEM-T-CrdS plasmids were se-
quenced and found to be correct. The XhoI- and NotI-digested
blunt-ended pGEM-T-CrdS DNA fusions were sub-cloned in-frame into
the pEU-EO1™ vectors affording the three expression plasmids
pEU-EO1-His-CrdS, pEU-EO1-His-Xa-CrdS and pEU-EO1-His-TEV-CrdS.
These DNA fusions contained the coding region of CrdS and the se-
quences encoding 6xHis afﬁnity tags and either Factor Xa or TEV (Tobac-
co Etch Virus) proteolytic sites at their 5′-termini, followedwith cloning
overhang sequences of 9–12 bp long. The 6xHis tag and the TEV site in
the pEU-EO1-His-TEV-CrdS plasmidwere separated by a 7-residue link-
er DYDIPTT thatwas designed to facilitate cleavage of a 6xHis afﬁnity tag
via the TEV protease. The cleavage of 6xHis-TEV-CrdS with the latter
protease would leave an additional Gly residue at the NH2-terminus of
CrdS, while the cleavage with the Factor Xa protease afforded an intact
NH2-terminus of CrdS.
3.2. CrdS is synthesised during wheat germ cell-free protein synthesis in
bilayer mode and co-translationally inserted in liposomes
Efﬁciency of wheat germ CF protein synthesis (WG-CFPS) system
was investigated in bilayer mode adopting de-coupled transcription
and translation reaction modes. The translation was carried out for
16 h at 20 °C in the presence of DMPC liposomes with all three
pEU-EO1-His-CrdS, pEU-EO1-His-Xa-CrdS and pEU-EO1-His-TEV-CrdS
mRNAs. As indicated in Fig. 1, with all three DNA fusions, SDS-PAGE
proﬁles showed good yield of CrdS in the presence of DMPC liposomes.
Here, low μg quantities of CrdS/150 μl of reaction mixtures were
obtained (Fig. 1, lanes 1–3), while no CrdS was synthesised in the reac-
tion mixture lacking mRNA (Fig. 1, lane 4). We observed a discrepancy
between migration of the synthesised 6xHis-CrdS, 6xHis-Xa-CrdS and
6xHis-TEV-CrdS proteins on the SDS-PAGE gels and their theoretical
molecular masses, however this anomaly was not unprecedented [35].
The data presented in Fig. 1 (lane 3) with the His-TEV-CrdS con-
struct was corroborated in a separate experiment (Fig. 2). Theidentity of the synthesised CrdS protein was veriﬁed through West-
ern blot using the anti-CrdS antibody (Fig. 2B, lanes 1 and 2). In addi-
tion, synthesis of CrdS was also conﬁrmed by detection with alkaline
phosphatase-conjugated streptavidin (Fig. 2C, lanes 1 and 2). Our
next task was to assess, if synthesised CrdS was co-translationally
inserted in the DMPC liposomes or if CrdS aggregated during transla-
tion (Fig. 2). When the translation reactionwithCrdSwas separated into
the supernatant and pellet fractions by centrifugation, the synthesised
CrdS protein remained associated with the pellet fraction while hardly
any CrdS protein was detected in the supernatant, pointing to the fact
that CrdS may have been successfully reconstituted in DMPC liposomes
(Figs. 2C and 3). As indicated in Fig. 2B, CrdS could efﬁciently be detected
with the rabbit polyclonal antibody, raised against the intracellular cata-
lytic region of CrdS [2], or with the streptavidin-alkaline phosphatase
conjugate (Fig. 2C). In the latter case, streptavidin targets biotinylated ly-
sine residues that had been incorporated into CrdS during CFPS from
biotinylated tRNA. Hence, this assay allows for detection of only newly
synthesised CrdS protein molecules from CrdS mRNA. It is of note that
the higher molecular mass protein bands that migrated between 70
and 250 kDa (Fig. 2C) resulted from the detection of native biotinylated
proteins contained in the wheat germ extract, and not due to oligomeric
assemblies of CrdS. Notably, the protein of about 130 kDa size found in
all preparations (Fig. 2B) most likely represented a wheat germ protein
as it was not detected via alkaline phosphatase-conjugated streptavidin
(Fig. 2C).
To conﬁrm that the pellet fraction contained the CrdS DMPC-
liposomes and not simply aggregated CrdS, the proteo-liposomes of
approximately 100 nm diameter were subjected to ﬂoatation by
Accudenz density gradient ultra-centrifugation and then detected
[36]. As indicated in Fig. 3 (lane 3), fractions with the CrdS
proteo-liposomes detected with anti-CrdS antibody, ﬂoated near the
top of the gradient. This observation highlighted the fact that over
95% of CrdS was successfully inserted co-translationally in the
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Fig. 2. SDS-PAGE and Western immuno-blot analyses of WG-CFPS translation reactions
performed in bilayer mode and supplemented with DMPC (2.5 mg/ml) liposomes.
Lanes 1 and 2 (duplicates) in the Coomassie stained panel A, and in the Western
immuno-blot with the anti-CrdS antibody (panel B), contain translation reactions with
His-TEV-CrdS mRNA, and lane 3 represents the reaction lacking mRNA. Lane 1 in the
Western immuno-blot detected via alkaline phosphatase-conjugated streptavidin
(panel C) contains the total WG-CFPS translation reaction, and lanes 2 and 3 repre-
sent separated pellet and supernatant fractions, respectively. The black arrows
point to synthesised CrdS that migrate to a region of 56–60 kDa; CrdS theoretical
mass is 73–76 kDa. St. indicates molecular mass standards.
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was found at the bottom of the test tube in the form of an aggregate
(Fig. 3 inset, lane 10). Further, the ﬂoatation through Accudenz densi-
ty gradient using ultra-centrifugation substantially improved the pu-
rity of the CrdS proteo-liposomes. The puriﬁed CrdS-liposomal
preparations (Fig. 4A) and those without CrdS (empty DMPC lipo-
somes) were imaged by transmission electron microscopy (TEM). In
these images (Fig. 4), the proteo-liposomes with or without CrdS
appeared as rounded objects, sizes of which ranged between 80 and
100 nm. No signiﬁcant variations in the appearance of liposomes
with and without reconstituted CrdS were observed (Fig. 4A and B).
Notably, in both cases fusion of unilamellar liposomes into the
multilamellar structures was observed.
3.3. Screening of CrdS production using wheat germ cell-free protein
synthesis in bilayer mode with liposomes prepared from a variety of
lipids
The next question to address was whether other types of lipids
could also lead to successful incorporation of CrdS in their bilayers.
We investigated the effects of lipids on CrdS synthesis in the
high-throughput bilayer mode. Here, CrdS was synthesised in the
presence of a variety of liposomes, prepared from a single zwitterion-
ic, anionic and cationic lipid components or a mixture of lipids at con-
centrations ranging from 2.5 mg/ml to 10 mg/ml (Table 3). The CrdS
protein synthesised under these conditions was detected directly on
SDS-PAGE gels, as described in the Materials and methods section.
The yields of CrdS synthesised in the presence of liposomes prepared
from a variety of lipids are summarised in Fig. 5. The highest yields of
CrdS occurred with liposomes prepared from zwitterionic lipids DMPC
and with liposomes prepared from soybean asolectin and E. coli lipids,followed by liposomes prepared from zwitterionic DOPC and POPC
(Fig. 5). No CrdSwas synthesised in the presence of liposomes prepared
from charged lipids, i.e.DOPG (anionic lipid) andDOTAP (cationic lipid).
However surprisingly, when the liposomes were prepared from DOPG
(anionic lipid) and POPE (zwitterionic lipid) in a ratio of 2:3 by weight,
the CrdS proteinwas synthesised (Fig. 5). The liposomes prepared from
the total lipid extract of E. coli also led to high yield of CrdS; this yield
was comparable to that during CFPS with the zwitterionic DMPC and
with the asolectin liposomes. The conclusion from these experiments
was that lipid type and composition were of paramount importance
for a successful co-translational insertion of CrdS in high yields.
3.4. CrdS production through wheat germ cell-free protein synthesis in
bilayer mode with surfactants, surfactant peptides and amphipols
A range of surfactants, surfactant peptides and amphipols were
screened during CFPS of CrdS (Table 2, Figs. 6 and 7). The list of sur-
factants, their sources and concentrations that were above their
CMC are summarised in Table 2. The effect of the tested surfactants
on synthesis of CrdS was variable (Fig. 6). Out of nine surfactants test-
ed (Table 2), four surfactants namely Brij-58, digitonin, Triton X-100
and Tween 80 were compatible with CFPS, leading to production of
CrdS in a soluble form, while with β-OG, NP40 and CHAPS the CrdS
synthesis was not observed (data not shown). The highest yields of
CrdS were achieved with Brij-58, followed by digitonin, Triton
X-100 and Tween 80 (Fig. 6).
CFPS of CrdS in the presence of the three acetylated surfactant
peptides Ac-AAAAAAD (Ac-Ala-Ala-Ala-Ala-Ala-Ala-Asp), Ac-IIID
(Ac-Ile-Ile-Ile-Asp), and Ac-LLLK-NH2 (Ac-Leu-Leu-Leu-Lys-NH2) was
carried out at 1 mM, 2 mM and 4 mM concentrations (Fig. 7). The
CrdS protein was synthesised in the presence of all the three peptides,
although the yields of CrdS varied. CrdS yieldwas higher in the presence
of Ac-AAAAAAD and Ac-IIID at 1 mM and 2 mM concentrations (Fig. 7,
lanes 3–4 and 6–7), compared to that with Ac-LLLK-NH2 (Fig. 7, lanes
9–10). Notably, at 4 mM concentrations of the surfactant peptides,
CrdS synthesis was either decreased or inhibited, in particular with
Ac-AAAAAAD (Fig. 7, lanes 5, 8 and 11).
Finally, the presence of amphipols A8-35 and SMA in 0.5% (w/v) to
4% (w/v) concentrations was found to be inhibitory during CFPS of
CrdS (data not shown).
3.5. Synthesis of CrdS with Brij-58 in dialysis mode and puriﬁcation of
CrdS through Immobilized Metal Afﬁnity Chromatography
Optimal conditions for WG-CFPS of CrdS in bilayer mode were se-
lected to set up a reaction in dialysis mode, as described in the
Materials and methods section. The synthesis was carried out in the
presence of 0.04% (w/v) Brij-58 for 24 h, 48 h and 72 h, and the reac-
tion mixtures were analysed by SDS-PAGE (Fig. 8, lanes 1–3). Based
on our semi-quantitative estimations, yield of CrdS in the presence
of Brij-58 was as high as 1 mg/ml after 48 h (Fig. 8, lane 2) and this
yield remained unchanged after the next 24-hour incubation period
(Fig. 8, lane 3).
The CrdS protein synthesised through dialysis mode in the pres-
ence of Brij-58 was puriﬁed by Immobilized Metal Afﬁnity Chroma-
tography (IMAC) using a Ni-NTA afﬁnity resin. The data in Fig. 9
indicate that CrdS could be puriﬁed signiﬁcantly from a crude transla-
tion reaction by IMAC, and that reasonable purity of CrdS was
achieved in the fractions eluted with 150 mM, 200 mM, 250 mM im-
idazole (Fig. 9, lanes 9–11). On the other hand, contaminating compo-
nents were removed during the 20 mM imidazole washing steps
(Fig. 9, lanes 3–6). The protein sample eluted with 250 mM imidazole
contained the highest amount of CrdS with fewer contaminants as
detected on the Coomassie Brilliant Blue R-250-stained SDS-PAGE
gel (Fig. 9, lane 11, black arrow). The purity of CrdS (Fig. 9, lane 11),
which should be the only newly synthesised membrane protein in
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Fig. 3. Density gradient ultra-centrifugation of the CrdS proteo-liposomes made from DMPC. Western immuno-blot analysis was performed with the anti-CrdS antibody. Lanes 1–10
represent fractions collected after ultra-centrifugation. Lane 3 contains the fraction with CrdS that has successfully been incorporated in DMPC liposomes and lane 11 contains a
non-fractionated WG-CFPS translation reaction mixture supplemented with the DMPC liposomes. The inset shows the membrane stained with Ponceau S. The black arrows
point to synthesised CrdS that migrates to a region of 56–60 kDa; CrdS theoretical mass is 73–76 kDa. St. indicates molecular mass standards.
750 A. Periasamy et al. / Biochimica et Biophysica Acta 1828 (2013) 743–757this preparation, was estimated to be between 50% and 60%. This esti-
mation formed a basis for stoichiometry to assemble CrdS nanodiscs.
3.6. CrdS synthesised throughwheat germ cell-free synthesis is a full-length
protein
CrdS synthesised in the presence of Brij-58 in dialysis mode was
puriﬁed by IMAC, and analysed by SDS-PAGE and the WesternA B
Fig. 4. TEM of the DMPC liposomes with (panel A) and wiimmuno-blot analysis using the anti-6xHis antibody and the rabbit
polyclonal antibody, raised against the intracellular CM of CrdS [2].
The protein band corresponding to CrdS was excised from the
SDS-PAGE gel and subjected to tryptic digestion. The analysis of tryptic
fragments was performed by MALDI-TOF/TOF MS (Table 4). A Mascot
database searches of the peptide sequences matched perfectly the gen-
erated peptide ions to the putative (1,3)-β-D-glucan synthase catalytic
subunit (GenBank accession AF057142) (Table 4).thout (panel B) CrdS. The lines indicate sizes of 1 μm.
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Fig. 5. Yields of CrdS duringWG-CFPSwith of liposomes prepared from a variety of lipids.
CrdS yields are given inmg/ml for liposomes prepared fromDMPC (2.5–10 mg/ml), DOPC
(2.5 mg/ml), POPC (5 mg/ml), DOPG:POPE=2:3 ratio by weight (5 mg/ml), asolectin
(5 mg/ml) and the total extract of lipids from E. coli (5 mg/ml). The numbers in brackets
indicate lipid concentrations that were optimal for WG-CFPS. No synthesis occurred with
DOPG and DOTAP (data not shown). CrdS quantiﬁcation was performed using the ImageJ
software [27]. The standard errors are shown as vertical bars and were determined from
three measurements.
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The CrdS protein synthesised in the presence of Brij-58 and puri-
ﬁed by IMAC as described above, was reconstituted in the E. coliMr (kDa)
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Fig. 6. SDS-PAGE analysis of WG-CFPS translation reactions performed in bilayer mode and
actions lacking mRNA. Lanes 2–7 (supernatant and pellet fractions) represent the His-TEV-C
ton X-100. The concentrations of surfactants used in WG-CFPS are listed in Table 2. Black arrtotal lipid extract or POPC nanodiscs (Fig. 10). Here, the CrdS:lipid:
MSP components were mixed in a 0.5:120:1 molar ratio and follow-
ing surfactant removal, the self-assembled nanodiscs were puriﬁed
by SEC on the Superdex 200 column. As indicated in Fig. 10A, both
types of CrdS nanodiscs eluted at signiﬁcantly faster rates than the
empty POPC nanodiscs (Fig. 10A), while the remaining MSP protein
and other contaminant proteins eluted later (18–23 ml) (Fig. 10A).
To conﬁrm that the CrdS protein successfully reconstituted in the
E. coli total lipid extract and POPC nanodiscs, the fractions from SEC
that eluted between 6 and 9 ml (Fig. 10A) were pooled, concentrated
and examined by silver-stained SDS-PAGE (Fig. 10B) coupled with a
Western immuno-blot analysis on PVDF membranes (Fig. 10C). As
documented in Fig. 10B and C (lanes 2 and 3), the CrdS protein
could successfully be detected using both analytical approaches. No-
tably, the Western immuno-blot analysis operated within a detection
limit (Fig. 10C, lanes 2 and 3) using the mouse anti-6xHis monoclonal
antibody. This observation suggested that 6xHis tag could be partly
obscured after CrdS is reconstituted in nanodiscs. We could also ob-
serve that the CrdS proteins reconstituted in the E. coli lipids or
POPC nanodiscs migrated on the SDS-PAGE gel in a form of diffused
bands. These protein bands, which are delineated by two arrowheads
(Fig. 10B, and C, lanes 2 and 3) migrated slightly slower than CrdS pu-
riﬁed by IMAC (Fig. 10C, lane 1, white arrow). We suggest that these
differences in CrdS migration could result from a tight association of
CrdS with lipids. Contrary to these speciﬁc associations of CrdS with
the E. coli or POPC lipids, puriﬁed CrdS migrated in a form of a sharp
protein band in the absence of lipids (Fig. 10C, white arrow). To de-
termine morphological properties of CrdS nanodiscs, they were im-
aged by TEM prior to SEC. The TEM images of CrdS nanodiscs made
from E. coli lipids (Fig. 10D, top panel) and POPC (Fig. 10D, bottom
panel), indicated that these nanoparticles appeared poly-disperse in
nature (Fig. 10D). Although a substantial proportion of both types of7 1 2 3 4 5 6 7
Pellets
supplemented with surfactants. Lane 1 (supernatant and pellet fractions) contains re-
rdS mRNA reactions in the presence of digitonin, DM, DDM, Brij-58, Tween 80 and Tri-
ows point to highest yields of synthesised CrdS. St. indicates molecular mass standards.
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Fig. 7. Anti-CrdS antibody Western immuno-blot analysis of WG-CFPS translation reactions performed in bilayer mode and supplemented with surfactant peptides. Lanes 1 and 2
represent reactions lacking mRNA, and with His-TEV-CrdS mRNA and 0.04% (w/v) Brij-58, respectively. Lanes 3–5, 6–8 and 9–11 contain the His-TEV-CrdS mRNA reactions in the
presence of 1 mM, 2 mM and 4 mM Ac-AAAAAAD, 1 mM, 2 mM and 4 mM Ac-IIID and 1 mM, 2 mM and 4 mM Ac-LLLK-NH2, respectively. The black arrows point to highest yields
of synthesised CrdS. St. indicates molecular mass standards.
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observed (Fig. 10D; white and black arrows in top and bottom panels).3.8. Characterisation of CrdS nanodiscs by small-angle X-ray scattering
using synchrotron radiation
To ﬁnd out if the SEC-puriﬁed CrdS nanodiscs were formed correctly
as the bilayer-embedded membrane protein complexes, the puriﬁed
CrdS nanodiscs were characterised by SAXS (Fig. 11). The SAXS proﬁles
of CrdS reconstituted in the E. coli total lipid extract or POPC nanodiscs
were typical of those reported for other membrane-inserted proteins
in nanodisc bilayer environments. These nanodiscs typically have a
characteristic broad maximum at ~0.1 Å that corresponds to the phos-
pholipid bilayer [37,38]. Using an indirect Fourier transformation (IFT)
approach [31,39], the scattering density distributions of the protein–
lipid complexes were determined (Fig. 11, inset) that provided a
real-space representation of the scattering data. The distributions for
both CrdS nanodiscs showed alternating positive and negative peaks
at short distances (b50 Å), reﬂecting the complex contrast landscape
across the bilayer resulting from the lower scattering length density of
the inner alkyl layer relative to solvent (TBS buffer). An extended tail
of positive scattering density was observed with the maximum particle
diameter (Dmax) approaching ~175 Å for both CrdS nanodiscs, indicat-
ing that solvent-exposed CrdS extended into solution away from the
membrane. These quantitative particle diameter data of both types of
CrdS nanodiscs agreed well with those obtained through TEM imaging
(cf. Figs. 10D and 11). The scattering density distributions suggested
that an approximate bilayer width of the puriﬁed CrdS nanodiscs was50 Å. Again, the latter parameter was consistent with the distributions
reported in the literature [37,38,40].3.9. CrdS synthesised with the surfactant peptide Ac-AAAAAAD or
reconstituted in the E. coli liposomes exhibits (1,3)-β-D-glucan synthase
activity
The CrdS enzyme is believed to operate as the UDP-glucose:
(1,3)-β-D-glucan 3-β-D-glucosyltransferase (EC 2.4.1.34). Thus, to
ﬁnd out if CrdS was synthesised in a catalytically active form,
(1,3)-β-D-glucan synthase activity assays were carried out. This
assay directly evaluates synthesis of the (1,3)-β-D-glucan product,
where the formed radioactive product is collected by ﬁltration on
Millipore ﬁlters and its radioactivity is evaluated by scintillation
counting [34]. Because high yields of the CrdS protein were required
for these enzyme activity measurements, CrdS was synthesised in
the presence of the surfactant Brij-58 and the surfactant peptide
Ac-AAAAAAD, or co-translationally inserted in the E. coli total lipid
extract liposomes, in dialysis mode. A mixed membrane fraction iso-
lated from S. cerevisiae and containing a membrane-associated
(1,3)-β-D-glucan synthase [33,34], served as a positive control for
these (1,3)-β-D-glucan synthase activity measurements.
The data in Table 5 indicated that CrdS synthesised in the presence
of Brij-58 was not active, as there was no increase in radioactivity of
the (1,3)-β-D-glucan product synthesised from UDP-[3H]-glucose serv-
ing as a donor substrate. Similarly, CrdS that was reconstituted in E. coli
total lipid extract or POPC nanodiscs was found to be catalytically in-
competent (Table 5). Conversely, the CrdS proteins synthesised with
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Fig. 8. SDS-PAGE analysis of WG-CFPS translation reactions performed through dialysis
mode. Lane 1 represents the reaction lacking mRNA, and lanes 2–4 contain the
His-TEV-CrdS mRNA reactions with 0.04% (w/v) Brij-58 after 24 h, 48 h and 72 h, respec-
tively. The black arrows point to synthesised CrdS. St. indicatesmolecularmass standards.
Mr (kDa)
250
150
100
75
50
37
25
20
15
10
St. 1 2 3 4 5
Fig. 9. SDS-PAGE analysis of CrdS puriﬁed via IMAC in the presence of 0.04% (w/v) Brij-58.
ponents collected as ﬂow-through following incubation of the CFPS reaction with the Ni-NTA
lanes 3–6. Lanes 7–12 indicate fractions eluted with 50 mM, 100 mM, 150 mM, 200 mM, 2
estimated to be between 50% and 60%. The black arrow points to puriﬁed CrdS. St. indicate
Table 4
Amino acid sequences of tryptic fragments of CrdS identiﬁed by MALDI-TOF/TOF.
CrdS tryptic peptidesa
SIIAAQAMDYPR
TYCEAVGVNYVTRPDNK
VAVVQTPQFYFNSDPIQHNLGIDK
VFFDVFQPAK
WCLGTIQIGLLR
FGKEEMIGVDFR
ITGLSTENITLAAVPSSSDVKDVFVPEAGWMR
a Amino acid sequences are indicated in a 1-letter code.
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E. coli liposomes, were active (Table 5). The average speciﬁc activities,
calculated from two independent measurements, were 0.18 mU/mg
and 0.22 mU/mg of protein for CrdS synthesised with Ac-AAAAAAD or
for CrdS co-translationally inserted in the E. coli liposomes, respectively
(Table 5). In comparison, the speciﬁc activity of (1,3)-β-D-glucan
synthase isolated from the S. cerevisiae membranes was 1.97 mU/mg
protein (Table 5). The latter value was nearly tenfold higher than the
speciﬁc activities of CF-synthesised CrdS, which was not surprising as
the nativemixedmembrane fractions of S. cerevisiaewere used for activ-
ity measurements.
4. Discussion
Membrane proteins are fundamental to essential cellular func-
tions, yet information on their structural and functional properties
is limited. At the end of August 2012, around 355 unique 3D struc-
tures of membrane monotopic and polytopic β-barrel and α-helical
proteins have been deposited in databases (http://blanco.biomol.6 7 8 9 10 11 12
Lane 1 contains a crude translation reaction before IMAC. Lane 2 shows unbound com-
beads. Components removed during the 20 mM imidazole washing steps are shown in
50 mM and 500 mM imidazole. Purity of the CrdS preparation shown in lane 11 was
molecular mass standards.
B C
 M
r
 (kDa) 
        250
        150
 
        100
 
          75
  
          50
  
          37
          25
   
          20
St. 1 2 3 St. 1 2 3
 M
r
 (kDa) 
        250
 
        150
 
        100
 
          75
  
 
          50
  
          37
          25
   
          20
D
Elution volume (ml)
0 6 12 18 24
m
AU
 (A
28
0)
0
4
8
12
Empty POPC Nanodiscs  
CrdS POPC Nanodiscs 
CrdS E. coli Nanodiscs 
A
Fig. 10. Reconstitution of CrdS in nanodiscs. Nanodisc assembly (from Escherichia coli lipids or POPC and MSP1E3D1) proceeded as described in the Materials and methods section.
Panel A, shows an elution proﬁle of the CrdS nanodiscs during SEC on the Superdex 200 10/300 GL column. Full line, dashed and dotted traces indicate elution volumes of the CrdS
nanodiscs prepared from the E. coli lipids (full line) or POPC (dashed line) and those of POPC empty nanodiscs (dotted line), respectively. In silver-stained SDS-PAGE (panel B), lane
1 contains 75° ng of BSA per lane, and lanes 2 and 3 represent the reconstituted CrdS nanodiscs made from the E. coli lipids and POPC, respectively. The respective top arrowheads
and the bottom arrows point to CrdS and MSP1E3D1. A known amount of BSA in lane 1 (75° ng) was used to estimate the protein concentration of CrdS. Panel C, in Western im-
muno-blot detected with the anti 6xHis antibody, lane 1 contains IMAC-puriﬁed CrdS (white arrow), and lanes 2 and 3 represent the reconstituted CrdS nanodiscs made from the E.
coli lipids and POPC, respectively. The arrowheads, bound by brackets in panels B and C, point to a diffused band of CrdS, respectively. The bottom arrow indicates MSP1E3D1. In
panels B and C, St. indicates molecular mass standards. Panel D shows the TEM images of the CrdS nanodiscs made from E. coli lipids (top panel) or POPC (bottom panel). White and
black arrows show the clustered CrdS nanodiscs. A substantial proportion of CrdS nanodiscs is non-clustered. The lines correspond to 100° nm.
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soluble proteins. The reasons for this low incidence of 3D membrane
protein structures compared to those of soluble proteins are many-
fold. For example, membrane proteins exist in low abundance and a
variety of conceptual difﬁculties associated with their production
and isolation remain unresolved. Although, relatively simple cloning
of membrane proteins' cDNA into a diversity of vector systems is
prevalent [41–45], membrane proteins' production, puriﬁcation and
crystallisation are less successful and require extensive effort. To
this end, the majority of 3D structures of resolved membrane proteins
were produced in bacterial hosts, and fewer of them have been
obtained in yeast, insect, mammalian cells or through CFPS [10,11].
CFPS systems are an alternative to cell-based systems, the popu-
larity of which started growing only recently with the advent ofrobotised synthesisers and other technical and conceptual advances
[21,22]. An advantage of CFPS is that they allow preparing membrane
proteins without residual lipids that are typically co-extracted from
membranes and thus researchers can control the lipid composition
and environment of synthesised membrane proteins. It has been
suggested that the lipid environment around proteins in membranes
is responsible for functional modulation of membrane proteins. One
of the main CFPS platforms currently used is a eukaryotic wheat
germ extract CFPS platform [10–14,17–22], which has been applied
in the current work. It has been well documented that WG-CFPS sys-
tems enable rapid production of proteins and thus this platform plays
an important role in modern functional genomics [10,11,17–22]. This
system holds promise in particular for eukaryotic membrane proteins
[10,11], as they almost always require post-translational modiﬁcations
Fig. 11. SAXS of CrdS nanodiscs prepared from the E. coli or POPC lipids and MSP1E3D1.
The SAXS proﬁles of the E. coli total lipid extract or POPC nanodiscs with reconstituted
CrdS are indicated in black or blue circles, respectively. Inset shows regularised curves
from the IFT ﬁtting procedure used to generate the real space scattering density distri-
bution functions, p(r). Fits and density distributions of the E. coli lipids or POPC
nanodiscs with reconstituted CrdS are shown as black and blue solid lines, respectively.
The SAXS proﬁles are offset for clarity.
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ation, phosphorylation, etc.
In the current work, our target CrdS transferase enzyme is conﬁned
within cell membranes of Agrobacterium sp. [2]. This enzyme is believed
to catalyse formation of a (1,3)-β-D-glucan (curdlan) polymer by a re-
petitive addition of glucosyl residues from the UDP-glucose donor sub-
strate. CrdS as a GT2 family glycosyl transferase enzyme (CAZy
database) is clustered with other plant membrane enzymes of para-
mount signiﬁcance, such as cellulose, (1,3)-β-D-glucan and (1,3;1,4)-
β-D-glucan synthases [2–4]. The CrdS protein harbours seven mem-
brane spanning α-helices, contains a single CM and has a predicted
Nout–Cin topology [2]. Only a few 3D structures of the GT2 enzymes
were elucidated up to date, notably all of them by X-ray crystallography
[5–7, Polani, Kumaran, Burley and Swaminathan, unpublished data].
However, all these enzymes do not harbour membrane α-helices and
essentially embody catalytic modules that fold into α/β architectures
[5–7, Polani, Kumaran, Burley and Swaminathan, unpublished data].
Thus, an urgency to resolve a 3D structure of a membrane-associated
transferase enzyme in the GT2 family remains.
Our previous attempts to obtain sufﬁcient yield of the full-length
CrdS protein in the E. coli host for 3D structural, biochemical and bio-
physical analyses failed [2]. In these experiments we used a variety of
bacterial vectors (e.g. pET15b, pBAD24, Champion™, pET SUMO™),
but irrespective of the conditions, the heterologous expression led to
production of truncated forms of CrdS that were produced via abortive
translation. Hence, in our current study we concentrated our efforts on
CFPS of full-length CrdS based on a well-deﬁned wheat germ system,Table 5
(1,3)-β-D-Glucan synthase activity of CrdS prepared through wheat germ cell-free syn-
thesis in the presence of surfactant Brij-58 and surfactant peptide Ac-AAAAAAD, and of
CrdS co-translationally inserted in the E. coli total lipid extract liposomes, or
reconstituted in the E. coli total lipid extract and POPC nanodiscs.
Sample Speciﬁc activity (mU/mg protein)a
CrdS with Brij-58 0
CrdS with Ac-AAAAAAD 0.18±0.06
CrdS in E. coli lipid extract liposomes 0.22±0.05
CrdS in E. coli lipid extract nanodiscs 0
CrdS in POPC nanodiscs 0
Mixed membrane fraction of S. cerevisiae 1.97±0.07
a A mean of two independent measurements.which has been documented to produce sufﬁcient amounts of proteins
for both analytical and preparative purposes [10,11,46].
When investigating the initial conditions for WG-CFPS of CrdS,
we established that the purities of plasmid DNA fusions, expressed
as a A260/A280 ratio for transcription reactions (the suitable range is
1.8–2.0), as well as purities of mRNAs for translation reactions
(lack of low molecular mass mRNA species of less than 500 bp)
were of paramount importance to detect synthesis of full-length CrdS
and obtain good yield. We methodically examined the efﬁciency of
WG-CFPS in bilayer and dialysis modes, using a wide range of surfac-
tants, surfactant peptides and amphipols, and of liposomes prepared
from a variety of lipids. We found optimal conditions for excellent yield
of CrdS in the presence of surfactants, surfactant peptides, and liposomes.
The best performing surfactant was with Brij-58, which is considered to
be mild, probably owing to its low CMC [47]. On the other hand, the ad-
dition of amphipols A8-35 or SMA inhibited WG-CFPS of CrdS. The rea-
son for this inhibitory behaviour of amphipols is not fully understood
and could result from either functional de-stabilisation of ribosomes
contained inwheat germ, or that amphipols directly interferewith struc-
ture of ribosomes and thus CF synthesis. To this end, it has been
suggested that A8-35 and sulfonated amphipols may interact with
basic patches at surfaces of ribosomal nanoparticles [48].
The CrdS proteins containing 6xHis afﬁnity tag, or 6xHis afﬁnity
tag and Factor Xa or TEV proteolytic sites synthesised in WG-CFPS
typically migrated around the ranges of 56–60 kDa, though their cal-
culated masses are between 73 and 76 kDa. Although unexpected,
our observations with this anomalous migration of membrane CrdS
were not unprecedented, since it was previously observed that mem-
brane proteins' band positions do not always correlate with their for-
mula molecular masses [35]. Through tryptic mapping and Mascot
database searches, we found out that the generated peptide ions in
length of 10–32 amino acid residues, matched perfectly to the puta-
tive (1,3)-β-D-glucan synthase catalytic subunit (GenBank accession
AF057142). Hence, the MALDI-TOF/TOF MS analysis in conjunction
with Western immuno-blot detection unambiguously conﬁrmed
that full-length CrdS was synthesised through WG-CFPS.
Excellent yield of CrdS in the presence of artiﬁcial liposomes pre-
pared from E. coli lipid extract was obtained through WG-CFPS. This
high yield was not unexpected as CrdS is a membrane protein of a
bacterial origin. It has been estimated that the most abundant phos-
pholipid species (70%) in the inner membrane of E. coli is POPE [49].
It consequently seemed logical that the addition of POPE to DOPG,
by 3:2 weight ratio leads to CrdS synthesis, while DOPG alone did
not support synthesis. Surprisingly, when the liposomes prepared
from soybean asolectin lipids were added to CFPS translation reactions,
high yield of CrdS was also obtained. It is of note that the soybean
(plant) asolectin lipids represent a complex mixture of phospholipids
such as lecithin, cephalin and phosphatidylinositol in equal proportions,
along with minor amounts of other phospholipids and polar lipids.
To determine the liposome-associated topology of CrdS following
co-translational insertion, the CrdS protein was synthesised in the
presence of 100 nm DMPC liposomes. We surmised that in these li-
posomes, CrdS could either adopt Nout–Cin topology, Nin–Cout topolo-
gy or a mixture of both. Here, the Nout–Cin topology of CrdS was
predicted previously through the PRED-TMR algorithm [2,41]. If the
Nout–Cin topology was occurring in the DMPC liposomes, then the
NH2-terminus of the CrdS protein would protrude to the exterior of
the liposomes and CM would localise to the liposomal lumen. To
this end, the CrdS proteo-liposomes puriﬁed through ﬂoatation by
Accudenz density gradient ultra-centrifugation, were digested with
the TEV protease and analysed through a Western immune-blot analy-
sis. When the TEV-treated CrdS proteo-liposomes separated by
SDS-PAGE were detected with the anti-6xHis antibody, the reactivity
of the TEV-treated CrdS towards this antibody was signiﬁcantly dimin-
ished. Further, the protein band of TEV-treated CrdS on the SDS-PAGE
gel shifted to a lower molecular mass and became diffuse (data not
756 A. Periasamy et al. / Biochimica et Biophysica Acta 1828 (2013) 743–757shown). These observations suggested that in some CrdSmolecules, the
NH2-terminus harbouring the 6xHis tag could have been excised by the
TEV protease. Thus, in someDMPC liposomes, theNH2-terminus of CrdS
was likely pointing to the exterior of the liposomes, while the other li-
posomal population contained CrdS in the Nin–Cout topology. Hence, it
can be concluded that CrdS reconstituted in the DMPC liposomes
exhibited a random orientation. The possible explanation for this ran-
dom distribution could be in a diameter (100 nm) and hence
high-angle curvature of proteo-liposomes. This curvature could hinder
proper insertion of large CM of CrdS into the liposomal lumen, whereas
larger diameter proteo-liposomes may be conducive to the correct
Nout–Cin topology of CrdS.
Recombinant CrdS synthesised with the Ac-AAAAAAD surfactant
peptide or co-translationally inserted in the E. coli lipid extract lipo-
somes was found to be active. On the other hand, CrdS synthesised
with Brij-58 or reconstituted in the E. coli lipids and POPC nanodiscs
was inactive. The latter observation indicates that the CrdS protein
synthesised with the surfactant Brij-58 may not have been properly
folded and also that reconstitution of CrdS in nanodiscs could not re-
store CrdS's catalytic activity. However, the observation that CrdS
synthesised with the surfactant peptide Ac-AAAAAAD was active, may
suggest that surfactant peptides could self-assemble to form a belt sur-
roundingmembrane proteins leading to formation of a stable surfactant
peptide-membrane protein complex [50]. To ﬁnd out if the radioactive
material synthesised by CrdS (and by the mixed membrane fractions
of S. cerevisiae) produced the (1,3)-β-D-glucan polymer, the radioactive
material was hydrolysed by the (1,3)-β-D-exo-glucanase enzyme that is
known to hydrolyse (1,3)-β-D-glucan through an exo-hydrolytic mech-
anism to glucose [33,34]. Gratifyingly, we found that the radioactivity
incorporated in the (1,3)-β-D-glucan product had decreased in all
cases by approximately 60% by the (1,3)-β-D-exo-glucanase treatment,
indicating that a substantial proportion of the material synthesised by
CrdS corresponded to the (1,3)-β-D-glucan product. Conversely, the
treatment with a boiled (1,3)-β-D-exo-glucanase or α-amylase left the
radioactivity incorporated in the (1,3)-β-D-glucan product unchanged,
again conﬁrming the chemical identity of the synthesised product.
Reconstitution of membrane proteins in nanodiscs, pioneered by
Sligar and co-workers has been described with membrane proteins
of various lengths [23,24,51,52]. The advantage of this technique is
generation of homogenous nanoscale lipid bilayers, which enclose a
desired membrane protein that is exposed to aqueous environments
on both sides. These nanodiscs can then be subjected to biophysical,
enzymatic and structural investigations. These nanoscale particles
can be effortlessly handled similar to soluble proteins, as their mem-
brane components are shielded by the lipid bilayer milieu, although,
speciﬁc challenges during nanodiscs construction remain. To this
end, the bottleneck represents a gentle isolation or production of a
speciﬁc membrane protein that can be obtained from biological
sources, or expressed and synthesised.
To reconstitute the CrdS protein in nanodiscs, ﬁrstly CrdS had to
be synthesised in the presence of a mild surfactant Brij-58 in high
yield and puriﬁed by IMAC. We estimated that nearly 90% of CrdS
could be recovered by this puriﬁcation technique. Subsequently, the
surfactant-solubilised CrdS protein was subjected to spontaneous as-
sembly with MSP1E3D1 and either the E. coli lipids or a zwitterionic
POPC lipid, resulting in spontaneous formation of CrdS:lipid:MSP
nanodiscs. The CrdS-containing nanodiscs were then puriﬁed by SEC
to near homogeneity and both SDS-PAGE and Western immuno-blot
analyses indicated the presence of CrdS in these artiﬁcial bilayers
(Fig. 10). When the CrdS-containing nanodiscs were subjected to
SDS-PAGE, the CrdS protein migrated slightly slower than CrdS puri-
ﬁed by IMAC, most likely due to associations of CrdS with lipids. These
data also indicated that the CrdS protein bound lipid molecules tightly
and that the presence of SDS could not entirely abolish these protein–
lipid associations. The precise reasons, why CrdS nanodiscs eluted near
the void volume during SEC are at present not known. We suggest thatat least two factors may play a role. More precisely, the CrdS protein,
after assembling in nanodiscs, could cause formation of asymmetrical
particles. This could be due to occurrence of a large catalytic module
and a COOH-terminal extension being positioned on one side of the
nanodisc bilayer, while the other side of the bilayer contains short
loops inter-connecting individual α-helices [2]. Second, CrdS nanodiscs
could form clusters of aggregated or stacked particles, formation of
which could be mediated by Brij-58 that remains to be tightly associat-
ed with the CrdS protein during CFPS.
The CrdS-loaded nanodiscs puriﬁed by SEC were characterised by
SAXS. Our experimental SAXS data were found to be consistent with
membrane insertion of the CrdS protein into the bilayer of both E. coli
lipids- and POPC-formed nanodiscs. The SAXS data provided evidence
that CrdS nanodiscs have been formed [37,38,40] and gave us conﬁdence
to reconstitute CrdS in these bilayers for future, more detailed structural
studies. Future work will focus on parameter extraction and modelling
from samples at higher concentrations, particularly in the differentiation
of empty and CrdS-loaded nanodiscs, and in separation of protein and li-
pidic scattering via contrast variation in small-angle neutron scattering
experiments. Future work will also expand upon the initial studies
presented in our current work, and explore in-depth bilayer insertion
and membrane perturbation caused by CrdS in nanodiscs formed from
the E. coli lipids and POPC, and from a variety of other lipids.
Finally, meaningful studies of polysaccharide synthases such as
CrdS are rare [53] and progress on structural descriptions of
β-D-glucan synthases has been slow-moving [3]. This is particularly
accurate for synthases of the GT2 family, which contains enzymes
required for the synthesis of polysaccharides such as cellulose,
(1,3)- and (1,3;1,4)-β-D-glucans [2,3]. It has proved problematic to pu-
rify these enzymes from nearly any biological material [2,3], because of
a membrane location of these polysaccharide synthases, their low con-
centration in cellular tissues and a tendency to lose enzyme activity fol-
lowing tissue disruption and isolation. For these reasons, CFPS systems
using cDNA fusions offer an alternative route to prepare sufﬁcient
amounts of polysaccharide synthases for structural, physicochemical,
kinetic and substrate speciﬁcity studies.
5. Conclusions
A set of suitable procedures based on WG-CFPS has been developed
leading to high yield of an integral membrane CrdS enzyme from
Agrobacterium sp. that is classiﬁed by the Enzyme Commission as
UDP-glucose: (1,3)-β-D-glucan 3-β-D-glucosyltransferase (EC 2.4.1.34).
Here, we synthesised full-length CrdS as evidenced by MALDI-TOF/TOF
MS, from the pEU-EO1™ plasmids, containing a 6xHis afﬁnity tag and ei-
ther Factor Xa or TEV proteolytic sites. CFPS afforded good yield of CrdS
with a variety of surfactants, surfactant peptides and liposomes through
bilayer and dialysis modes. The dialysis mode with the surfactant Brij-58
afforded between 1 and 2 mg/ml quantities of CrdS. IMAC puriﬁed CrdS
synthesised with Brij-58 was assembled in the E. coli lipids or POPC
nanodiscs. CrdS synthesised in the presence of the surfactant peptide
Ac-AAAAAAD and co-translationally inserted in the E. coli liposomes
was catalytically competent. We expect that these rapid and efﬁcient
WG-CFPS procedures could be used for generation of other membrane
catalysts, particularly where large quantities of proteins are required
for downstream functional, structural and other applications.
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